Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Tuesday, April 23, 2024 | Back issues
Courthouse News Service Courthouse News Service

Pharma Patents

WASHINGTON - After Glycobiosciences had regulators reinstate the patent it claims Innocutis Holdings infringes with its product Bionect, a federal judge denied Innocutis judgment on the pleadings Wednesday.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...